English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52535983    Online Users :  748
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"lin z z"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 111-135 of 330  (14 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-08-20T02:45:42Z Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study KUO-HSING CHEN; Shao Y.-Y.; Chen H.-M.; Lin Y.-L.; Lin Z.-Z.; Lai M.-S.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-08-12T04:01:31Z A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor YANG SHIH-HUNG; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; Hong R.-L.
臺大學術典藏 2021-08-12T04:01:31Z Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma YANG SHIH-HUNG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏 2021-08-10T03:53:07Z A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor SHIH-HUNG YANG; Lin C.-C.; Lin Z.-Z.; Tseng Y.-L.; Hong R.-L.
臺大學術典藏 2021-08-10T03:53:07Z Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏 2021-07-13T06:04:31Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; LEE JIH-HSIANG; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-07-03T03:34:48Z Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; PEI-JER CHEN; Shao Y.-Y.; Ding Y.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:46Z Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; PEI-JER CHEN; Lin Z.-Z.; Chao T.-Y.; Cheng A.-L.
臺大學術典藏 2021-07-03T03:34:37Z Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma Shao Y.U.-Y.; PEI-JER CHEN; Lin Z.-Z.; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-07-02T03:21:35Z Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer WEN-CHI YANG; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2021-06-28T06:52:26Z The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases Chiang Y.; Yang J.C.-H.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Lin Z.-Z.; KENG-HSUEH LAN; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2021-06-25T08:49:28Z The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases YUN CHIANG; Yang J.C.-H.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Lin Z.-Z.; Lan K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2021-05-07T02:46:37Z Young patients with colorectal cancer have increased risk of second primary cancers YI-HSIN LIANG; Shao Y.-Y.; Chen H.-M.; Lai C.-L.; Lin Z.-Z.; Kuo R.N.; Cheng A.-L.; Yeh K.-H.; Lai M.-S.
臺大學術典藏 2021-05-03T09:17:12Z Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life Hsieh C.-C.;Chao-Chi Ho;Lin Z.-Z.;Yu C.-J.;Jow G.-M.;Huang F.-Y.;Shih J.-Y.;Hsiao F.-H.; Hsieh C.-C.; CHAO-CHI HO; Lin Z.-Z.; Yu C.-J.; Jow G.-M.; Huang F.-Y.; Shih J.-Y.; Hsiao F.-H.
臺大學術典藏 2021-05-02T03:49:15Z Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life Hsieh C.-C.;Ho C.-C.;Lin Z.-Z.;Yu C.-J.;Jow G.-M.;Huang F.-Y.;Jin-Yuan Shih;Hsiao F.-H.; Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; Yu C.-J.; Jow G.-M.; Huang F.-Y.; JIN-YUAN SHIH; Hsiao F.-H.
臺大學術典藏 2021-05-02T03:29:26Z Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life Hsieh C.-C.;Ho C.-C.;Lin Z.-Z.;Chong-Jen Yu;Jow G.-M.;Huang F.-Y.;Shih J.-Y.;Hsiao F.-H.; Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; CHONG-JEN YU; Jow G.-M.; Huang F.-Y.; Shih J.-Y.; Hsiao F.-H.
臺大學術典藏 2021-04-29T05:09:17Z Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:15Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; KUAN-YU CHEN; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C.
臺大學術典藏 2021-04-29T05:08:55Z Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib Yao Z.-H.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:51Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Kuan-Yu Chen;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; KUAN-YU CHEN; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-04-29T05:08:51Z Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Kuan-Yu Chen;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.-H.;Yu C.-J.; Yao Z.-H.; Liao W.-Y.; Ho C.-C.; KUAN-YU CHEN; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-04-27T08:36:02Z The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia HUNG-YANG KUO; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; Cheng W.-F.; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
臺大學術典藏 2021-04-27T08:11:51Z The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia HUNG-YANG KUO; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; Shao Y.-Y.; Hsu C.; Cheng W.-F.; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
臺大學術典藏 2021-04-23T05:56:29Z Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer Yang W.-C.;Hsu F.-M.;Chen Y.-H.;Shih J.-Y.;Yu C.-J.;Lin Z.-Z.;Lu S.-H.;Chih-Hsin Yang;Cheng A.-L.;Kuo S.-H.; Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; Yu C.-J.; Lin Z.-Z.; Lu S.-H.; CHIH-HSIN YANG; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2021-03-19T06:57:53Z Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment Lin Z.-Z.; Hsu C.; YEUN-CHUNG CHANG; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.

Showing items 111-135 of 330  (14 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page